Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors

Gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN) is known to overexpress somatostatin receptors (SSTRs), most commonly SSTR2 and SSTR5. The expression of SSTRs on tumor cells forms the basis for somatostatin analog treatment of patients with NEN. The present study detected the expression of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncol Lett
Hauptverfasser: Wang, Yuhong, Wang, Wei, Jin, Kaizhou, Fang, Cheng, Lin, Yuan, Xue, Ling, Feng, Shiting, Zhou, Zhiwei, Shao, Chenghao, Chen, Minhu, Yu, Xianjun, Chen, Jie
Format: Artigo
Sprache:Inglês
Veröffentlicht: D.A. Spandidos 2017
Schlagworte:
Articles
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5403486/
https://ncbi.nlm.nih.gov/pubmed/28454229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2017.5591
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge